DNA Sciences Enters Deal to Acquire PPGx | GenomeWeb

NEW YORK, Dec 18 - DNA Sciences said Monday it had entered an agreement to acquire PPGx, a pharmacogenomics products and services company, in an all stock deal.

In a statement DNA Sciences, which collects and studies DNA samples for disease-relevant SNPs, said that the combined companies would integrate their different scientific methodologies and research programs and pool patient sample collections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.